La nouvelle plateforme élimine les contraintes de cisaillement hydrodynamique et s’étend de manière isométrique de...
2026
NEW YORK, March 12, 2026 /PRNewswire/ — ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for...
LEXINGTON, Mass., March 12, 2026 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on...
SAN FRANCISCO, March 12, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for...
Biologics License Application (BLA) for INO-3107 accepted for review under the Accelerated Approval Program as...
Credit: Christoph Burgstedt/Getty Images Enodia Therapeutics, which develops small-molecule therapies for targeted protein degradation at...